This is a preview of subscription content, log in via an institution to check access.
Notes
2016 US dollars
Reference
Kim DJ, et al. Cost Effectiveness of Genotype-Guided Warfarin Dosing in Patients with Mechanical Heart Valve Replacement Under the Fee-for-Service System. Applied Health Economics and Health Policy : 28 Feb 2017. Available from: URL: http://doi.org/10.1007/s40258-017-0317-y
Rights and permissions
About this article
Cite this article
Genotype-guided warfarin cost effective in Asian MHVR patients. PharmacoEcon Outcomes News 773, 21 (2017). https://doi.org/10.1007/s40274-017-3806-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3806-1